id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1977-N-0049-0008,FDA,FDA-1977-N-0049,"Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Proposed Amendment to Tentative Final Monograph; Reopening of Comment Period",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2010-04-19T04:00:00Z,2010,4,2010-04-19T04:00:00Z,1994-05-05T03:59:59Z,2019-03-20T19:43:38Z,94-9354,0,0,09000064805da652
FDA-1977-N-0049-0005,FDA,FDA-1977-N-0049,"Internal Memorandum from William E. Gilbertson (HFD-810) to Dockets Management Branch (HFA-305) February 2, 1994",Other,Memorandum,2010-04-19T04:00:00Z,2010,4,2010-04-19T04:00:00Z,,2019-02-07T15:45:50Z,,0,0,0900006480adb24d
FDA-1977-N-0049-0006,FDA,FDA-1977-N-0049,Letter from Adrian I. Karp to FDA,Other,Letter(s),2010-04-19T04:00:00Z,2010,4,2010-04-19T04:00:00Z,,2019-02-07T15:53:59Z,,0,0,09000064805da64f
FDA-1977-N-0049-0004,FDA,FDA-1977-N-0049,"Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Proposed Amendment to Tentative Final Monograph",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2010-04-19T04:00:00Z,2010,4,2010-04-19T04:00:00Z,1994-04-05T03:59:59Z,2019-03-20T17:43:16Z,94-2265,0,0,09000064805da64e
FDA-1977-N-0049-0007,FDA,FDA-1977-N-0049,Request for Extension from Nonprescripton Drug Manufacturers Association,Other,Request for Extension,2010-04-19T04:00:00Z,2010,4,2010-04-19T04:00:00Z,,2019-02-12T13:25:32Z,,0,0,0900006480adb2c5
FDA-1977-N-0049-0010,FDA,FDA-1977-N-0049,Request for Extension from Nonprescripton Drug Manufacturers Association,Other,Request for Extension,2010-04-19T04:00:00Z,2010,4,2009-12-10T05:00:00Z,1992-04-23T03:59:59Z,2019-02-12T13:29:06Z,,0,0,09000064805da650
FDA-1977-N-0049-0003,FDA,FDA-1977-N-0049,List of References [FDA-1977-N-0049-0001],Supporting & Related Material,Background Material,2009-12-10T05:00:00Z,2009,12,,,2019-02-06T17:44:57Z,,0,0,0900006480a68e9e
FDA-1977-N-0049-0001,FDA,FDA-1977-N-0049,"Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Proposed Amendment to the Tentative Final Monograph",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2009-12-10T05:00:00Z,2009,12,2009-12-10T05:00:00Z,1992-04-23T03:59:59Z,2019-03-20T18:03:31Z,91-30424,0,0,09000064805da64d
FDA-1977-N-0049-0002,FDA,FDA-1977-N-0049,"Internal Memorandum from William E. Gilbertson (HFD-210) to Dockets Management Branch (HFA-305) December 24, 1991",Other,Memorandum,2009-12-10T05:00:00Z,2009,12,2009-12-10T05:00:00Z,,2019-02-07T14:57:56Z,,0,0,0900006480a68e9d